Chapter 53: Labor, Delivery & Postpartum Medications

Labor, Delivery & Postpartum Medications begins by outlining the four distinct stages of labor, from cervical dilation and effacement to the early stabilization phase following placental expulsion. Pain management is a central theme, highlighting the shift from nonpharmacologic techniques like hydrotherapy and relaxation to systemic analgesics, including opioid agonists such as fentanyl and mixed agonist-antagonists like nalbuphine. A major focus is placed on regional anesthesia, particularly lumbar epidurals and spinal blocks, which utilize local anesthetics like bupivacaine to provide targeted relief while maintaining maternal consciousness. The text details the critical role of uterotropic drugs, specifically synthetic oxytocin for labor induction and augmentation, alongside prostaglandins like dinoprostone for cervical ripening. Nursing priorities during administration include vigilant monitoring for uterine hyperstimulation and fetal heart rate abnormalities. Following delivery, the focus shifts to physiological recovery, where drugs like methylergonovine are utilized to prevent postpartum hemorrhage by promoting sustained uterine contractions. The postpartum section also addresses the management of perineal discomfort and hemorrhoids using topical agents like witch hazel or benzocaine, and the promotion of bowel health through stool softeners and stimulant laxatives. Emerging treatments for postpartum depression, such as the neuroactive steroid zuranolone, are introduced alongside established protocols for maternal immunizations. This includes the administration of Rh0(D) immune globulin to prevent isoimmunization in Rh-negative patients and the rubella vaccine to safeguard future pregnancies against congenital complications. Through this integrated approach, the chapter equips healthcare providers with the knowledge to balance maternal comfort, labor progress, and neonatal safety.